2026-2034年全球骨关节炎治疗市场规模、份额、趋势和成长分析报告

预计骨关节炎治疗市场规模将从 2025 年的 116.4 亿美元成长到 2034 年的 250.5 亿美元，2026 年至 2034 年的复合年增长率为 8.89%。

由于人口老化导致关节疾病发生率不断上升，全球骨关节炎治疗市场正在不断扩大。骨关节炎是全球最常见的肌肉骨骼疾病之一。肥胖率上升和久坐的生活方式加剧了疾病的流行。人们对有效缓解疼痛和提高生活品质的需求正在推动药物研发。

目前的治疗方法包括止痛药、消炎药和注射疗法。製药公司正在投资研发针对软骨退化根本原因的缓解疾病药物。医疗保健支出的成长和诊断能力的提高正在推动市场成长。新兴市场治疗途径的扩大进一步扩大了患者群体。

未来前景取决于创新治疗方法的成功研发。生物製药和再生医学的进步有望彻底改变治疗方法。公众意识的提高和早期诊断的普及将推动对治疗方案的需求。随着全球人口老化，骨关节炎治疗市场预计将保持稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球骨关节炎治疗市场：依药物类别划分

• 市场分析、洞察与预测
• 皮质类固醇
• 非类固醇消炎剂（NSAIDs）及其他
• 黏弹性补充剂

第五章 全球骨关节炎治疗市场：依给药途径划分

• 市场分析、洞察与预测
• 口服
• 肠外
• 局部的

第六章 全球骨关节炎治疗市场：依通路划分

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

第七章 全球骨关节炎治疗市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Horizon Pharma Plc
  • Pfizer Inc
  • Sanofi
  • Anika Therapeutics Inc
  • Ferring BV
  • Bioventus Inc
  • Chugai Pharmaceutical Co. Ltd
  • Alkem Laboratories
  • Flexion Therapeutics Inc
  • Zimmer Biomet Holdings Inc

The Osteoarthritis Drug Market size is expected to reach USD 25.05 Billion in 2034 from USD 11.64 Billion (2025) growing at a CAGR of 8.89% during 2026-2034.

The Global Osteoarthritis Drug Market is expanding due to the rising prevalence of joint disorders among aging populations. Osteoarthritis is one of the most common musculoskeletal conditions worldwide. Increasing obesity rates and sedentary lifestyles contribute to disease incidence. Demand for effective pain management and improved quality of life drives pharmaceutical development.

Current treatments include analgesics, anti-inflammatory drugs, and injectable therapies. Pharmaceutical companies are investing in research for disease-modifying drugs that target underlying cartilage degeneration. Growing healthcare expenditure and improved diagnostic capabilities support market growth. Access to treatment in emerging markets further expands patient reach.

Future prospects depend on successful development of innovative therapies. Advances in biologics and regenerative medicine may transform treatment approaches. Increased awareness and early diagnosis will drive demand for therapeutic solutions. As the global population ages, the osteoarthritis drug market is expected to sustain steady growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Class

• Corticosteroids
• NSAIDs and Others
• Viscosupplementation Agents

By Route of Administration

• Oral
• Parenteral
• Topical

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Horizon Pharma plc, Pfizer Inc, Sanofi, Anika Therapeutics Inc, Ferring BV, Bioventus Inc, Chugai Pharmaceutical Co Ltd, Alkem Laboratories, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. NSAIDs and Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Viscosupplementation Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Parenteral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OSTEOARTHRITIS DRUG MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Class
  • 7.2.2 By Route Of Administration
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Class
  • 7.3.2 By Route Of Administration
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Class
  • 7.4.2 By Route Of Administration
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Class
  • 7.5.2 By Route Of Administration
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Class
  • 7.6.2 By Route Of Administration
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OSTEOARTHRITIS DRUG INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Horizon Pharma Plc
  • 9.2.2 Pfizer Inc
  • 9.2.3 Sanofi
  • 9.2.4 Anika Therapeutics Inc
  • 9.2.5 Ferring B.V
  • 9.2.6 Bioventus Inc
  • 9.2.7 Chugai Pharmaceutical Co. Ltd
  • 9.2.8 Alkem Laboratories
  • 9.2.9 Flexion Therapeutics Inc
  • 9.2.10 Zimmer Biomet Holdings Inc